Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
Authors
Keywords
-
Journal
GENE THERAPY
Volume 24, Issue 7, Pages 377-384
Publisher
Springer Nature
Online
2017-05-04
DOI
10.1038/gt.2017.35
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Superparamagnetic Iron Oxide Nanoparticles Modified with Tween 80 Pass through the Intact Blood–Brain Barrier in Rats under Magnetic Field
- (2016) Yinping Huang et al. ACS Applied Materials & Interfaces
- Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
- (2016) R Kaminski et al. GENE THERAPY
- HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay
- (2016) Sara Sunshine et al. JOURNAL OF VIROLOGY
- Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System
- (2016) Shefah Qazi et al. MOLECULAR PHARMACEUTICS
- Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
- (2016) Bo Wang et al. MOLECULAR THERAPY
- Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
- (2016) Sheena M Saayman et al. MOLECULAR THERAPY
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
- (2016) Ming Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly efficient baculovirus-mediated multigene delivery in primary cells
- (2016) Maysam Mansouri et al. Nature Communications
- CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape
- (2016) Zhen Wang et al. Cell Reports
- Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
- (2016) Rafal Kaminski et al. Scientific Reports
- Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers
- (2016) Ajeet Kaushik et al. Scientific Reports
- Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9
- (2016) Kristine E. Yoder et al. Scientific Reports
- A new model for post-integration latency in macroglial cells to study HIV-1 reservoirs of the brain
- (2015) Martha Schneider et al. AIDS
- Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing
- (2015) Wujin Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Sustained-release nanoART formulation for the treatment of neuroAIDS
- (2015) Rahul Jayant et al. International Journal of Nanomedicine
- Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation
- (2015) Maria Antonietta De Luca et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- MicroRNA-155 Reinforces HIV Latency
- (2015) Debbie S. Ruelas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS
- (2015) Vidya Sagar et al. Journal of Biomedical Nanotechnology
- PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier
- (2015) C. Fornaguera et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles
- (2015) Lei Wang et al. JOURNAL OF DRUG TARGETING
- Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
- (2015) Chang Li et al. JOURNAL OF GENERAL VIROLOGY
- Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging
- (2015) Asahi Tomitaka et al. Nanoscale
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Damaging the Integrated HIV Proviral DNA with TALENs
- (2015) Christy L. Strong et al. PLoS One
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
- (2015) Kathrin Schumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core
- (2015) Andrew J. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
- (2015) Weijun Zhu et al. Retrovirology
- Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
- (2015) Marc Zuckermann et al. Nature Communications
- Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
- (2015) Panpan Hou et al. Scientific Reports
- CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs
- (2015) Yonggang Zhang et al. Scientific Reports
- HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells
- (2015) Leonard Chavez et al. PLoS Pathogens
- CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
- (2014) Randall J. Platt et al. CELL
- Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
- (2014) Hiroshi Nishimasu et al. CELL
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study
- (2014) R. K. Heaton et al. CLINICAL INFECTIOUS DISEASES
- Eradication of human immunodeficiency virus from brain reservoirs
- (2014) Avindra Nath JOURNAL OF NEUROVIROLOGY
- Enhanced blood–brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation
- (2014) Hong Ding et al. NANOTECHNOLOGY
- Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
- (2014) Carolin Anders et al. NATURE
- Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
- (2014) Dirk Heckl et al. NATURE BIOTECHNOLOGY
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
- (2014) Weiming Wang et al. PLoS One
- Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
- (2014) Courtney V. Fletcher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
- (2014) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The microRNA miR-29a is associated with human immunodeficiency virus latency
- (2014) Paresh Patel et al. Retrovirology
- Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation
- (2014) M. Jinek et al. SCIENCE
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5
- (2013) Dawn A. Maier et al. HUMAN GENE THERAPY
- Epigenetic Regulation of HIV-1 Latency in Astrocytes
- (2013) S. D. Narasipura et al. JOURNAL OF VIROLOGY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
- (2013) Krzysztof Chylinski et al. RNA Biology
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers
- (2013) Madhavan Nair et al. Nature Communications
- Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
- (2013) Hirotaka Ebina et al. Scientific Reports
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- FLASH assembly of TALENs for high-throughput genome editing
- (2012) Deepak Reyon et al. NATURE BIOTECHNOLOGY
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Chromatin Reassembly Factors Are Involved in Transcriptional Interference Promoting HIV Latency
- (2011) E. Gallastegui et al. JOURNAL OF VIROLOGY
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
- (2011) Feng Zhang et al. NATURE BIOTECHNOLOGY
- Targeted Genome Editing Across Species Using ZFNs and TALENs
- (2011) Andrew J. Wood et al. SCIENCE
- Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load
- (2010) Susan Cu-Uvin et al. AIDS
- Low Frequency of Intermittent HIV-1 Semen Excretion in Patients Treated with Darunavir-Ritonavir at 600/100 Milligrams Twice a Day plus Two Nucleoside Reverse Transcriptase Inhibitors or Monotherapy
- (2010) S. Lambert-Niclot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus–Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy
- (2010) Ronald J. Ellis ARCHIVES OF NEUROLOGY
- A TALE nuclease architecture for efficient genome editing
- (2010) Jeffrey C Miller et al. NATURE BIOTECHNOLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- HIV integration site distributions in resting and activated CD4+ T cells infected in culture
- (2009) Troy Brady et al. AIDS
- Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia
- (2009) Melissa J. Churchill et al. ANNALS OF NEUROLOGY
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
- Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
- (2008) Tina Lenasi et al. Cell Host & Microbe
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
- (2008) Tae‐Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search